The mechanism of enzymatic and non-enzymatic N-oxide reductive metabolism of cyadox in pig liver

References

• Barham HM, Stratford IJ. (1996). Enzymology of the reduction of the novel fused pyrazine mono-n-oxide bioreductive drug, RB90740 roles for P450 reductase and cytochrome b5 reductase. Biochem Pharmacol 51:829–837.
   PubMed Web of Science ®Google Scholar
• Bickel MH. (1969). The pharmacology and biochemistry of N-oxides. Pharmacol Rev 21:325–355.
   PubMed Web of Science ®Google Scholar
• Chang WS, Chiang HC. (1995). Structure-activity relationship of coumarins in xanthine oxidase inhibition. Anticancer Res 15:1969–1973.
   PubMed Web of Science ®Google Scholar
• Ding MX, Wang YL, Zhu HL, Yuan ZH. (2006). Effects of cyadox and olaquindox on intestinal mucosal immunity and on fecal shedding of Escherichia coli in piglets. J Anim Sci 84:2367–2373.
   PubMed Web of Science ®Google Scholar
• Ding MX, Yuan ZH, Wang YL, Zhu HL, Fan SX. (2006). Olaquindox and cyadox stimulate growth and decrease intestinal mucosal immunity of piglets orally inoculated with Escherichia coli. J Anim Physiol Anim Nutr. 90:238–243.
   PubMed Web of Science ®Google Scholar
• Fang G, He Q, Zhou S, Wang D, Zhang Y, Yuan Z. (2006). Subchronic oral toxicity study with cyadox in Wistar rats. Food Chem Toxicol 44:36–41.
   PubMed Web of Science ®Google Scholar
• Ge X, Wang J, Liu J, Jiang J, Lin H, Wu J, Ouyang M, Tang X, Zheng M, Liao M, Deng Y. (2010). The catalytic activity of cytochrome P450 3A22 is critical for the metabolism of T-2 toxin in porcine reservoirs. Catal Commun 12:71–75.
   Web of Science ®Google Scholar
• He Q, Fang G, Wang Y, Wei Z, Wang D, Zhou S, Fan S, Yuan Z. (2006). Experimental evaluation of cyadox phototoxicity to Balb/c mouse skin. Photodermatol Photoimmunol Photomed 22:100–104.
   PubMed Web of Science ®Google Scholar
• Huang L, Wang Y, Tao Y, Chen D, Yuan Z. (2008). Development of high performance liquid chromatographic methods for the determination of cyadox and its metabolites in plasma and tissues of chicken. J Chromatogr B 874:7–14.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Shimizu Y, Shiraga Y, Yoshida M, Sugihara K, Ohta S. (2002). Reductive metabolism of p,p’-DDT and o,p’-DDT by rat liver cytochrome P450. Drug Metab Dispos 30:113–118.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Sugihara K, Tatsumi K. (1999). A unique tertiary amine N-oxide reduction system composed of quinone reductase and heme in rat liver preparations. Drug Metab Dispos 27:92–97.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Tatsumi K. (1984a). Involvement of liver aldehyde oxidase in the reduction of nicotinamide N-oxide. Biochem Biophys Res Commun 120:602–606.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Tatsumi K. (1984b). Reduction of tertiary amine N-oxides by liver preparations: function of aldehyde oxidase as a major N-oxide reductase. Biochem Biophys Res Commun 121:749–754.
   PubMed Web of Science ®Google Scholar
• Liu Z, Huang L, Dai M, Chen D, Tao Y, Wang Y, Yuan Z. (2009). Metabolism of cyadox in rat, chicken and pig liver microsomes and identification of metabolites by accurate mass measurements using electrospray ionization hybrid ion trap/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 23:2026–2034.
   PubMed Web of Science ®Google Scholar
• Murray KN, Chaykin S. (1966). The reduction of nicotinamide N-oxide by xanthine oxidase. J Biol Chem 241:3468–3473.
   PubMed Web of Science ®Google Scholar
• Nabuurs MJ, Van der molen EJ, De Graaf GJ, Jager LP. (1990). Clinical signs and performance of pigs treated with different doses of carbadox, cyadox and olaquindox. Zentralbl Veterinarmed A 37:68–76.
   PubMedGoogle Scholar
• Obach RS, Huynh P, Allen MC, Beedham C. (2004). Human liver aldehyde oxidase: inhibition by 239 drugs. J Clin Pharmacol 44:7–19.
   PubMed Web of Science ®Google Scholar
• Panoutsopoulos GI, Beedham C. (2004). Kinetics and specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase towards substituted benzaldehydes. Acta Biochim Pol 51:649–663.
   PubMed Web of Science ®Google Scholar
• Powis G, Svingen BA, Dahlin DC, Nelson SD. (1984). Enzymatic and non-enzymatic reduction of N-acetyl-p-benzoquinone imine and some properties of the N-acetyl-p-benzosemiquinone imine radical. Biochem Pharmacol 33:2367–2370.
   PubMed Web of Science ®Google Scholar
• Przybyszewski WM, Malec J. (1987). Hydroxyurea, methotrexate and adriblastine can mediate non-enzymatic reduction of nitroblue tetrazolium with NADH which is inhibited by superoxide dismutase. Biochem Pharmacol 36:3312–3314.
   PubMedGoogle Scholar
• Raleigh SM, Wanogho E, Burke MD, Patterson LH. (1999). Rat cytochromes P450 (CYP) specifically contribute to the reductive bioactivation of AQ4N, an alkylaminoanthraquinone-di-N-oxide anticancer prodrug. Xenobiotica 29:1115–1122.
   PubMed Web of Science ®Google Scholar
• Riley RJ, Workman P. (1992). Enzymology of the reduction of the potent benzotriazine-di-N-oxide hypoxic cell cytotoxin SR 4233 (WIN 59075) by NAD(P)H: (quinone acceptor) oxidoreductase (EC 1.6.99.2) purified from Walker 256 rat tumour cells. Biochem Pharmacol 43:167–174.
   PubMedGoogle Scholar
• Shimada S, Mishima H, Kitamura S, Tatsumi K. (1987). Nicotinamide N-oxide reductase activity in bovine and rabbit eyes. Invest Ophthalmol Vis Sci 28:1204–1206.
   PubMed Web of Science ®Google Scholar
• Skalova L, Nobilis M, Szotakova B, Wsol V, Kubicek V, Baliharova V, Kvasnickova E. (2000). Effect of substituents on microsomal reduction of benzo(c)fluorene N-oxides. Chem Biol Interact 126:185–200.
   PubMedGoogle Scholar
• Stohrer G, Brown GB. (1969). Purine N-oxides. 28. The reduction of purine N-oxides by xanthine oxidase. J Biol Chem 244:2498–2502.
   PubMed Web of Science ®Google Scholar
• Sugihara K, Kitamura S, Tatsumi K. (1996). S-(-)-nicotine-1’-N-oxide reductase activity of rat liver aldehyde oxidase. Biochem Mol Biol Int 40:535–541.
   PubMedGoogle Scholar
• Sugiura M, Iwasaki K, Noguchi H, Kato R. (1974). Evidence for the involvement of cytochrome P-450 in tiaramide N-oxide reduction. Life Sci 15:1433–1442.
   PubMed Web of Science ®Google Scholar
• Takekawa K, Kitamura S, Sugihara K, Ohta S. (2001a). Non-enzymatic reduction of aliphatic tertiary amine N-oxides mediated by the haem moiety of cytochrome P450. Xenobiotica, 31:11–23.
   PubMed Web of Science ®Google Scholar
• Takekawa K, Sugihara K, Kitamura S, Ohta S. (2001b). Enzymatic and non-enzymatic reduction of brucine N-oxide by aldehyde oxidase and catalase. Xenobiotica 31:769–782.
   PubMed Web of Science ®Google Scholar
• Takekawa K, Sugihara K, Kitamura S, Tatsumi K. (1997). Nonenzymatic reduction of brucine N-oxide by the heme group of cytochrome P450. Biochem Mol Biol Int 42:977–981.
   PubMedGoogle Scholar
• Walton MI, Wolf CR, Workman P. (1992). The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liver. Biochem Pharmacol 44:251–259.
   PubMed Web of Science ®Google Scholar
• Wang X, He QH, Wang YL, Ihsan A, Huang LL, Zhou W, Su SJ, Liu ZL, Yuan ZH. (2010). A chronic toxicity study of cyadox in Wistar rats. Regul Toxicol Pharmacol 59:324–33.
   PubMedGoogle Scholar
• Yubisui T, Matsukawa S, Yoneyama Y. (1980). Stopped flow studies on the nonenzymatic reduction of methemoglobin by reduced flavin mononucleotide. J Biol Chem 255:11694–11697.
   PubMedGoogle Scholar
• Zhang F, Estavillo C, Mohler M, Cai J. (2008). Non-enzymatic reduction of a 1,2,4-thiadiazolium derivative. Bioorg Med Chem Lett 18:2172–2178.
   PubMedGoogle Scholar